D-0104-2021 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0104-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Nov 6, 2020 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification The recall status is terminated (terminated Mar 23, 2022). Affected quantity: 4,416 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 2, 2020
Initiation Date
Nov 6, 2020
Termination Date
Mar 23, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,416 bottles

Product description

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30

Reason for recall

Failed Tablet/Capsule Specification

Distribution pattern

Product was distributed nationwide.

Code information

Lot# 20P0141, exp. date 02/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0104-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0104-2021. Report a data issue: hello@regdatalab.com.